Quarterly ResultApr 30, 2026, 06:07 AM
BHC Q1 Net Loss $(1.42)B on $1.43B Goodwill Impairment; Revenue +11.7%
AI Summary
Bausch Health Companies Inc. reported a significant net loss of $(1,431) million for Q1 2026, a substantial increase from $(86) million in Q1 2025, primarily driven by a $1,426 million goodwill impairment. Despite this, revenues grew by 11.7% to $2,524 million. The company continues to evaluate the full separation of its Bausch + Lomb eye health business, holding approximately 87% ownership. Operating cash flow improved to $230 million.
Key Highlights
- Net loss attributable to BHC was $(1,423) million, compared to $(58) million in Q1 2025.
- Goodwill impairments totaled $1,426 million in Q1 2026, up from $0 in Q1 2025.
- Total revenues increased 11.7% to $2,524 million from $2,259 million year-over-year.
- Basic and diluted loss per share was $(3.82), significantly worse than $(0.16) in Q1 2025.
- Net cash provided by operating activities rose to $230 million from $211 million.
- Current portion of long-term debt increased to $889 million from $225 million.
- Total assets decreased to $24,498 million from $26,366 million since Dec 31, 2025.
- Total shareholders' deficit widened to $(2,059) million from $(554) million.